3/21
11:36 am
tsha
Rating for TSHA
Low
Report
Rating for TSHA
3/21
04:48 am
tsha
Rating for TSHA
Medium
Report
Rating for TSHA
3/20
10:36 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
Medium
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
3/20
10:36 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
Medium
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
3/20
09:42 am
tsha
Rating for TSHA
High
Report
Rating for TSHA
3/20
09:42 am
tsha
Rating for TSHA
High
Report
Rating for TSHA
3/20
09:05 am
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Low
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
3/20
08:56 am
tsha
Rating for TSHA
Low
Report
Rating for TSHA
3/20
07:02 am
tsha
Rating for TSHA
Medium
Report
Rating for TSHA
3/20
07:02 am
tsha
Rating for TSHA
Medium
Report
Rating for TSHA
2/29
03:42 pm
tsha
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Low
Report
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
2/29
03:00 pm
tsha
Rating for TSHA
Low
Report
Rating for TSHA
2/29
03:00 pm
tsha
Rating for TSHA
Low
Report
Rating for TSHA